Wang, Shurui
Feng, Shumei
Shen, Aomei
Qiang, Wanmin
Tang, Qiang
Article History
Received: 17 September 2025
Accepted: 15 May 2026
First Online: 2 June 2026
Declarations
Ethics approval and consent to participate: This cross-sectional study was conducted in accordance with the Declaration of Helsinki guidelines, and the protocol was approved by the Medical Ethics Committee of Tianjin Cancer Hospital, with ethics approval number bc2021084. Informed consent was obtained from all participants included in the study.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.